CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-10 | REYNO LEONARD Chief Medical Officer | Shares withheld for taxes | −7,382 | $1.99 | $15K | 166,382 |
| 2025-07-01 | Anderson Kenneth Carl Director | Grant or award | +7,616 | $1.51 | $12K | 135,225 |
| 2025-07-01 | GROGAN DONNA ROY Director | Grant or award | +9,609 | $1.51 | $15K | 51,889 |
| 2025-06-18 | Koppikar Utpal Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-06-18 | Hughes Owen Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-06-18 | Fawell Stephen Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-06-18 | Anderson Kenneth Carl Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-06-18 | Bessen Laura Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-06-18 | GROGAN DONNA ROY Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-06-18 | Cooper Ronald Harold Wilfred Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-06-18 | Hoerter Steven L. Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2025-04-01 | GROGAN DONNA ROY Director | Grant or award | +9,581 | $1.44 | $14K | 42,280 |
| 2025-04-01 | Anderson Kenneth Carl Director | Grant or award | +7,841 | $1.44 | $11K | 127,609 |
| 2025-02-18 | Boyle Scott N Chief Business Officer | Sale 10b5-1 | −669 | $3.15 | $2K | 107,805 |
| 2025-02-15 | Hirsch Andrew President & CEO | Shares withheld for taxes | −9,370 | $3.18 | $30K | 423,145 |
| 2025-02-14 | Hirsch Andrew President & CEO | Grant or award | +223,500 | 445,362 | ||
| 2025-02-14 | Hirsch Andrew President & CEO | Shares withheld for taxes | −12,847 | $3.18 | $41K | 432,515 |
| 2025-02-14 | Hirsch Andrew President & CEO | Grant or award · Stock Option (Right to Buy) | +335,300 | 335,300 | ||
| 2025-02-14 | Siegel Jolie Chief Legal Officer | Grant or award | +56,500 | 110,853 | ||
| 2025-02-14 | Siegel Jolie Chief Legal Officer | Shares withheld for taxes | −2,914 | $3.18 | $9K | 107,939 |
Page 4 of 27 · 525 trades